Editor’s note: Local Tech Wire’s daily venture capital or investment firm today features one of the region’s most powerful players. Matthew Burns, Daniel Pearson and Worth Civils compiled the series, which appears Monday through Friday. Atlanta’s oldest and largest venture capital firm, Noro-Moseley Partners, has $580 million under management in five funds, including the Southeast’s largest at $320 million, which the firm closed on two years ago.

The portfolio of the 19-year-old firm reads like a who’s who of Southeastern technology companies, including OpenSite Technologies, SciQuest, SecureWorks, Novient, Ockham Technologies, Digital Furnace, Quantira Technologies, Norak Biosciences, EG Technology and ChemCodes.

In fact, over the past five years Noro-Moseley has made well over 100 deals.

Noro-Moseley tries to diversify its holdings, with investments in communications, health care and information technology as well as a few retail and other industries. It also likes to achieve a balance in its portfolio between early-stage and growth companies, with the latter category including profitable firms with more than $5 million in annual revenue.

The firm prefers the role of lead investor, acting as such in almost three-quarters of its deals, so it can leverage its network of contacts and the expertise of its advisors to help its portfolio companies. It typically makes an initial investment of $2 million to $5 million, with follow-on investments up to a total of $10 million.

Here’s the skinny:

Firm: Noro-Moseley Partners

Mailing address: 4200 Northside Parkway, Building 9 Atlanta, Ga. 30327

Phone number: (404) 233-1966

Web site: www.noro-moseley.com

Management Team:

Charles Moseley
Jack Kelly
Rusty French
Chuck Johnson
Alan Taetle
Allen Moseley
Steve Nussrallah

Focus of firm: Information technology, communications, medical technology

Size of current fund: $320 million

Money under management: $480 million

Companies funded over the last five years:

More than 115. Sample investments include ChemCodes, EG Technology, Inc., Flamenco, Inc., Norak Biosciences, Inc., and TradeUps, Inc.

How many new deals do you expect to fund in 2002: Undetermined

In what size range: $4 million to $10 million

Sweet Spot (types of deals, stage of the company): Startups, and first, second and late stage companies.

Most important attributes for companies seeking funding: Must be an established, privately owned growth company with experienced management.

What differentiates you: Management team has more than 50 years of combined venture capital experience, which enables us to deal with a broad range of financial and business issues.

Thursday’s profile: Richards Investment Capital

Previous profiles can be found under Venture Watch. Set date parameters for Feb.11 through today, hit enter, and see the VC related stories published since that date.

Previous profiles:

Feb. 11: Academy Venture Funds
Feb. 12: Atlantic Group
Feb. 13: Aurora Fund
Feb. 14: Capital Investment Partners
Feb. 15: Carolina Financial Group
Feb. 18: Carousel Capital
Feb. 19: Catalysta Partners
Feb. 20: Charlotte Angel
Feb. 21: Draper Atlantic
Feb. 22: Eno River
Feb. 25: Halifax Group
Feb. 26: Intersouth Partners
Feb. 27: Kitty Hawk Capital
Feb. 28: NC Enterprise Corp.

March 1: NC Technological Development Authority
March 4: Oberlin Capital
March 5: A.M. Pappas
March 6: Piedmont
March 7: RBC Centura
March 8: Redleaf Group
March 11: Remington Capital
March 12: River Cities
March 13: Research Triangle Ventures
March 14: Southeast Interactive
March 15: Tri-State Investment Group
March 18: Trelys
March 19: truePilot
March 20: Wakefield Group
March 21: Frontier Capital
March 22: Southern Capitol Ventures
March 25: Alliance
March 26: Armada
March 27: Cordova Ventures
March 28: Craven, Green & Wahlen
March 29: Intelligent Systems

April 1: Five Paces Ventures
April 2: Kinetic
April 3: Gray Ventures
April 4: Live Oak
April 5: Mellon Ventures
April 8: Linx
April 9: Monarch